Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of melatonin and mecobalamin in treatment of diabetic wound healing disorders

A technology for wound healing and diabetes, applied in the field of biomedicine, to achieve the effect of promoting healing

Active Publication Date: 2020-06-09
SHANDONG UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the inventor found that Mecobala has not been reported in the treatment of diabetic skin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of melatonin and mecobalamin in treatment of diabetic wound healing disorders
  • Application of melatonin and mecobalamin in treatment of diabetic wound healing disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] 1 Materials and methods

[0054] 1.1 Experimental animals

[0055] Twenty-four male SD rats (weight: 220 ± 20 g) aged about 8 weeks were purchased from the Experimental Animal Center of Shandong University. The experimental protocol has been approved by the Animal Experiment Ethics Committee of Shandong University School of Medicine (No. Authorization, the experiment strictly complied with the "Guidelines for Animal Care and Treatment" (eighth edition, 2011).

[0056] 1.2 Experimental materials and reagents

[0057] Melatonin (M5250-1G; Sigma-Aldrich, St.Louis, MO, USA); Mecobalt (Shanghai Aibison Biotechnology Co., Ltd.).

[0058] 1.3 Preparation of SD rat diabetic model and diabetic wound model

[0059] Fasting without food and water for 12 hours before modeling, blood glucose was measured at the end of the next morning. Subsequently, the hyperglycemia model was induced by intraperitoneal (i.p.) injection of streptozotocin (STZ; 75 mg / kg; Sigma-Aldrich, St) for th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of melatonin and mecobalamin in treatment of diabetic wound healing disorders, and belongs to the technical field of biological medicine. Research of the invention shows that the combined use of the melatonin and the mecobalamin can significantly promote healing of wound surfaces of diabetic rats, and the effect of the combined medication is better than that of the melatonin when used alone; the combined medication significantly promotes the healing of diabetic skin wounds by reducing inflammatory response at the wound part and increasing the number of epidermal stem cells; and a current status of diabetic wound treatment (difficult to heal and high costs of treatment) and the advantages of price and application safety of small molecule drugs such as the melatonin and the mecobalamin are combined, the research of the mixed preparation of the melatonin and the mecobalamin has important clinical practical value, and the research results of the invention provide a theoretical basis and novel treatment ideas for clinical application.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to the application of melatonin combined with mecobal in treating diabetic wound healing disorder. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Diabetes is a chronic metabolic disease that seriously endangers human health and quality of life. Research shows that the number of people with diabetes in the world was 415 million in 2015 and may reach 642 million by 2040. Complications caused by diabetes are the main cause of disability and death of diabetic patients. Delayed or non-healing ulcer wound healing is the primary factor for patients to be hospitalized o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/714A61K31/4045A61P3/10A61P29/00A61P17/02
CPCA61K31/4045A61K31/714A61P3/10A61P17/02A61P29/00A61K2300/00
Inventor 郝爱军姬光瑜周文娟李羡
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com